Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report
Henderson, Sara L., Teft, Wendy A., Kim, Richard B.Volume:
16
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-016-2342-x
Date:
December, 2016
File:
PDF, 676 KB
english, 2016